Safety of corticosteroid therapy in sarcoidosis treatment
Introduction: Sarcoidosis is a multisystemic granulomatous disease of unknown origin and unpredictable cause, characterized by a dysregulated immune response. If histopathological hallmark is represented by the presence of non-caseating granulomas, clinical manifestations are variable and symptoms a...
Saved in:
Main Authors: | Alessandro Di Marco Berardino, Federico Mei, Lina Zuccatosta |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-12-01
|
Series: | Frontiers in Drug Safety and Regulation |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fdsfr.2023.1319931/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cutaneous sarcoidosis successfully treated with PUVA therapy
by: Agata Szczecina, et al.
Published: (2025-01-01) -
Late onset of sarcoidosis in a patient with gastric MALT non-Hodgkin lymphoma
by: Martina Torchio, et al.
Published: (2014-08-01) -
Renal sarcoidosis: renal pathology guides diagnosis and prognosis
by: Aichun Liu, et al.
Published: (2024-12-01) -
A Comprehensive Review of Sarcoidosis: From Clinical Manifestations to Management Strategies
by: Olga Śpiołek, et al.
Published: (2024-12-01) -
Orbital and adnexal sarcoidosis: Clinical presentations and management outcomes
by: Shebin Salim, et al.
Published: (2025-02-01)